On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Lipid mediators
- Resolution of acute inflammation
- Schematic and histological sequence of events
- Glossary: from PUFA precursors to lipid mediators
- "Classic" lipoxin-generating pathways
- Lipoxins and ATL in resolution of inflammation
- Lipoxins counter-regulate signs of inflammation
- Production of 15-epi-lipoxins
- Rapid screening: fast pace to stable analogs
- 15-(R/S)-methyl LXA4 analog
- LX and ATL deficiencies in human disease
- From acute phase to resolution phase
- Outcome of inflammation: complete resolution
- Murine dorsal air pouch
- LC-MS-MS based profiling of lipid mediators
- LC-MS-MS results: 18R-HEPE
- Resolvin E1 stops PMN infiltration
- Biosynthesis of resolvin E1
- Identification of novel lipid mediators
- RvE1 in human plasma: mediator lipidomics
- Resolvins: actions of E series resolvins
- Resolvin E1: stereospecific total organic synthesis
- Localized aggressive periodontitis (LAP)
- Rabbit model for LAP
- RvE1 protects from inflammatory bone loss
- Receptor screening for counter-regulatory signals
- Specific GPCRs for resolvin E1 actions
- RvE1 acts via two distinct leukocyte GPCRs
- RvE1 transformation
- 19-para-fluoro-phenoxyl RvE1
- DHA precursor to resolvins and protectins
- Resolvins: actions of D series
- RvD1 and ATRvD1: human PMN transmigration
- Resolvins E and D series reduce murine peritonitis
- Protectins: DHA-derived 17S-series
- Biosynthesis of protectin D1/ neuroprotectin D1
- PD1 stops leukocyte infiltration
- Temporal-differential analyses of resolution
- Resolution in quantitative terms
- Upregulation of CCR5 during resolution
- Resolvins and protectins in humans - summary
- Resolvins and PD1 identified in murine kidney
- PD1 and RvD1
- Activity scores of mice treated with PD1 or RvDs
- Discovery of a deficiency disease in rats
- Normal vs. curled tail
- Summation: some key points to remember
- Resolvins and known pharmacological agents
- Resolvins & protectins- summary
- NIDCR
- Laboratory of professor Charles N. Serhan
Topics Covered
- Complete resolution of the acute inflammatory response and its return to homeostasis is essential
- Efforts to identify and characterize the cellular and molecular mechanisms that govern resolution of self-limited inflammation
- Systems approach with temporal analysis of the evolving inflammatory exudates using unbiased mediator lipidomics/informatics, proteomics, and cellular traffic with murine resolving exudates
- Novel endogenous pathways of local acting mediators that are dual acting, and that are both anti-inflammatory and pro-resolving
- Biosynthesis and actions of "resolvins" and "protectins"
- E-series resolvins and D-series resolvins
- Actions of neuroprotectin D-1
- Biosynthesis of aspirin-triggered lipid mediators and their impact in regulating acute inflammatory responses
- The resolution of acute inflammation is an active process that can be accelerated
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Serhan, C. (2020, May 1). Novel lipid mediators in resolution of inflammation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/YMBP5943.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Charles Serhan has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.